Showing results (311-320 of 426) with videos related to
Sort By:
Pageof 43
Nature Genetics|October 30, 2012
Bayesian refinement of association signals for 14 loci in 3 common diseases, Julian B Maller, Gilean McVean, et al.Cell|April 2, 2026
Rational discovery of therapeutic PAK1 allosteric activatorsYu He, James S H Bae, Elżbieta Nowak, et al.The New England Journal of Medicine|May 13, 2024
Aficamten for Symptomatic Obstructive Hypertrophic CardiomyopathyMartin S Maron, Ahmad Masri, Michael E Nassif, et al.American Heart Journal|May 13, 2015
Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' CollaborationAlex Pitcher, Jonathan Emberson, Ronald V Lacro, et al.Nature Genetics|February 7, 2012
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke, , Céline Bellenguez, et al.Plos Genetics|April 14, 2020
A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver diseaseConnor A Emdin, Mary E Haas, Amit V Khera, et al.Plos Genetics|April 6, 2021
Correction: A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver diseaseConnor A Emdin, Mary E Haas, Amit V Khera, et al.The New England Journal of Medicine|March 3, 2016
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease, Nathan O Stitziel, Kathleen E Stirrups, et al.Journal of the American College of Cardiology|February 18, 2017
Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery DiseaseThomas R Webb, Jeanette Erdmann, Kathleen E Stirrups, et al.Cell Metabolism|March 13, 2012
Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathwayHouman Ashrafian, Gabor Czibik, Mohamed Bellahcene, et al.Pageof 43